Rifamycin Sodium
Thông số
14897-39-3Số CAS
238-965-7Số EC
sodium (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-13-acetyloxy-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-27-olateTên IUPAC
C37H46NNaO12Công thức hóa học
719.7 g/molKhối lượng phân tử
RIFAMYCIN SODIUM; Rifamycin SV sodium; 14897-39-3; Rifamastene; Rifamycinum natricum; 32086GS35Z; UNII-32086GS35Z; EINECS 238-965-7; CB-0111; CB-01-11; RIFAMYCIN SODIUM (MART.); RIFAMYCIN SODIUM [MART.]; RIFAMYCIN SODIUM (EP IMPURITY); RIFAMYCIN SODIUM [EP IMPURITY]; RIFAMYCIN SODIUM (EP MONOGRAPH); RIFAMYCIN SODIUM [EP MONOGRAPH]; 2,7-(EPOXYPENTADECA(1,11,13)TRIENIMINO)NAPHTHO(2,1-B)FURAN-1,11(2H)-DIONE, 5,6,9,17,19,21-HEXAHYDROXY-23-METHOXY-2,4,12,16,18,20,22-HEPTAMETHYL-, 21-ACETATE, SODIUM SALT; Otofa; RefChem:57065; 238-965-7; SODIUM (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-21-(ACETYLOXY)-6,9,17,19-TETRAHYDROXY-23-METHOXY-2,4,12,16,18,20,22-HEPTAMETHYL-1,11-DIOXO-1,2-DIHYDRO-2,7-(EPOXYPENTADECA(1,11,13)TRIENIMINO)NAPHTHO(2,1-B)FURAN-5-OLATE; Rifamycin SV sodium salt; Rifamycin sodium salt; Rifamycin sodium [USAN]; Rifamyzin-Natrium; Rifamycin, sodium salt; CB-01-11, Rifamycin SV; DTXSID0040208; Aemcolo; Monosodium rifamycin SV; sodium;(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-13-acetyloxy-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-27-olate; Rifamycin, monosodium salt; Sodium rifomycin SV; MFCD09752825; C37H46NNaO12; NSC 133100; Rifamycin SV Monosodium; Rifamycin (sodium) (Standard); SCHEMBL29692909; HY-B1907R; RIFAMYCIN SODIUM [WHO-DD]; RIFAMYCIN SODIUM [ORANGE BOOK]; RIFAMYCIN SV SODIUM SALT [MI]; FR27730; Rifamycin SV sodium - Bio-X trade mark; 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, monosodium salt; 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, sodium; BR300118; SY107736; R3222; Q27256110; Rifamycin SV sodium salt, potency: >=900 units (dry basis); Rifaximin EP Impurity C Sodium Salt (Rifamycin SV Sodium Salt); 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11 (2H)-dione 21-acetate sodium salt; 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-acetate, sodium salt (1:1); SODIUM (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-21-(ACETYLOXY)- 6,9,17,19-TETRAHYDROXY-23-METHOXY-2,4,12,16,18,20,22-HEPTAMETHYL-1,11-DIOXO-1,2- DIHYDRO-2,7-(EPOXYPENTADECA(1,11,13)TRIENIMINO)NAPHTHO(2,1-B)FURAN-5-OLATE; Sodium (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-21-(acetyloxy)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-9-olate; sodium (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-13-acetyloxy-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-27-olate; sodium;(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-13-acetoxy-15,17,27,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-2-olateTên gọi khác
